# Nurix Therapeutics, Inc.: Form 8-K, filed Oct 6, 2022

- Company: [Nurix Therapeutics, Inc.](/companies/nrix.md) (CIK 1549595)
- Form: 8-K
- Filed: 2022-10-06
- Accepted by EDGAR: Oct 6, 2022, 16:10 ET
- Period: 2022-10-06
- Accession: 0001564590-22-033701
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1549595/000156459022033701/nrix-8k_20221006.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1549595/000156459022033701/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1549595/000156459022033701/nrix-8k_20221006.htm

Filed Oct 6, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-033701. Last ingested by Listed: Nov 5, 2026, 13:59 ET. No prices; not investment advice.